Oral cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer
Conditions
Interventions
None listed
Sponsors
Hokkaido University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age 20 years or older at the time of obtaining consent. (2) Patients whose disease originates in the oral cavity, mid-pharynx, hypopharynx, or larynx (3) Patients who are diagnosed with head and neck cancer and will receive chemoradiotherapy or radiotherapy as an inpatient at this hospital. (4) Patients who have already completed the inpatient treatment described in (iii) above and are currently or will be undergoing outpatient treatment. (5) Subjects who have been fully informed about their participation in this study, and who have given their free and voluntary written consent based on their full understanding of the study.
Exclusion criteria
Exclusion criteria: (1) Patients for treatment of recurrence or metastasis (2) Patients with a diagnosis of cognitive dysfunction or psychiatric disease (3) Patients with implantable medical devices (cardiac pacemakers, etc.) or medical devices necessary for life support (bioinformatics monitors) (4) Patients who will experience physical and mental stress due to participation in the research (5) Other patients whom the principal investigator judges to be inappropriate as research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patterns of change in sarcopenia and dynapenia indices from CRT/RT period to 12 months after completion of treatment (transition) | — |
Countries
Japan
Contacts
Public ContactNaomi Sumi
Hokkaido University Faculty of Health Sciences Nursing division
Outcome results
None listed